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Abstract
In the physiochemical sciences, plasma is used to describe an ionized gas. Previous studies
have implicated plasma surface treatment in the enhancement of hydrophilicity of implanted
musculoskeletal reconstructive materials. Hydroxyapatite (HA) ceramics, widely used in
bone tissue regeneration, have made great advancements to skeletal surgery. In the present
study, we investigate the impact of low-pressure plasma on the interconnected porous cal-
cium hydroxyapatite (IP-CHA) both in vitro and in vivo. Our results indicate that dielectric bar-
rier discharge (DBD) plasma, when used with oxygen, can augment the hydrophilicity of non-
porous HA surfaces and the osteoconductivity of the IP-CHA disc via increased water pene-
tration of inner porous structures, as demonstrated through microfocus computed tomogra-
phy (μCT) assay. In vivo implantation of plasma-treated IP-CHA displayed superior bone
ingrowth than untreated IP-CHA. Though plasma-treated IP-CHA did not alter osteoblast cell
proliferation, it accelerated osteogenic differentiation of seeded marrow mesenchymal stem
cells. In vitro X-ray photoelectron spectroscopy (XPS) revealed that this plasma treatment
increases levels of oxygen, rather than nitrogen, on the plasma-treated IP-CHA surface.
These findings suggest that plasma treatment, an easy and simple processing, can signifi-
cantly improve the osteoconductive potential of commonly used artificial bones such as IP-
CHA. Further optimization of plasma treatment and longer-term follow-up of in vivo applica-
tion are required toward its clinical application.
Introduction
Reconstruction of bone defects within clinical settings, through both autograft and allograft
treatments, has achieved varying degrees of success but warrants concerns of donor site mor-
bidity [1], potential immune responses, and risk of disease transmission [2]. As an attractive
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alternative to natural bone grafts, biocompatible and osteoconductive synthetic scaffolds have
been widely accepted within orthopedic, craniofacial, and dental disciplines [3–5]. Hydroxyap-
atite (HA) is a commonly used ceramic in bone regeneration due to its analogous chemical
composition to the mineral composites of the target tissue [6] and its affinity to integrate with
host tissue [7]. The pervasive use of HA in skeletal surgery has directed much effort towards
the advancement of HA-based biomaterials through surface modifications in order to reach
higher degrees of biocompatibility and osteocoductivity [8–10].
A group of researchers from Osaka University, including some of the present authors,
previously developed a fully open interconnected porous calcium hydroxyapatite ceramics
(IP-CHA), now an established bone substitute, commercially available in a clinical setting.
When implanted in an in vivo rabbit model, the IP-CHA increased in mechanical strength
with the formation of new bone, reaching up to three times its initial strength just 9 weeks
post-surgery [11]. Due to repetitive mechanical stress loading, early bone ingrowth is nec-
essary for early weight bearing [12, 13]. Treatments facilitating rapid bone ingrowth post
implantation can significantly improve the clinical efficacy of currently available bone
substitutes.
Plasma, a term used to describe an ionized gas in physicochemical science, can be classi-
fied as thermal or non-thermal on the basis of its creation. Thermal plasma is widely used as
a surface engineering/coating process through which metals and ceramics can be sprayed
onto other material. Metal particles such as titanium or silver as well as hydroxyapatite are
imparted on dental or orthopedic implants via a thermal plasma spraying technique to en-
hance their biocompatibility [14]. Conversely, the potential use of non-thermal plasma,
with its lower temperature, has been explored in medical applications for direct treatment
of living tissues through sterilization, blood coagulation [15], wound healing, and tissue
regeneration [16], or for indirect treatment through implantation of plasma-treated materi-
als into living tissues [17, 18]. Recent studies have established potential advantages of non-
thermal plasma treatment in biomaterials used for bone and cartilage regeneration [19, 20],
however, no studies have focused on biological effect of non-thermal plasma treatment on
porous HA bone substitute.
In the present study, we applied non-thermal plasma treatment to IP-CHA and evaluated
the potential of this simple and easy modification to enhance the biocompatibility of preexist-
ing materials. Specifically, we assessed its effect both in vitro and in vivo using rat calvarial




Samples of HA-coated culture plates (BD BioCoat™ Osteologic™, BD Bioscience, San Jose, CA,
USA), non-porous HA pellets (CELLYARD™, Pentax, HOYA Technosurgical Inc., Tokyo,
Japan), IP-CHA discs (NEOBONE™, Aimedic MMT, Tokyo, Japan) were processed. IP-CHA
discs with 75% porosity in volume, an average pore diameter of 150 μm, and an average inter-
pore-connection diameter of 40 μm were provided by Aimedic MMT Co Ltd. The non-porous
HA pellet and IP-CHA disc were 5 mm in diameter and 2 mm in height. All plasma-treated
materials were exposed to low-pressure plasma for a duration of 30 minutes, excluding non-
porous HA pellets, which were exposed for 5 minutes. Corresponding untreated material
served as negative controls in all experiments.
Mouse osteoblastic cell line, MC3T3-E1, was obtained from DS Pharma Biomedical
(Osaka, Japan).
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Animals
Twelve 7-week-old (300–400 g) male Sprague-Dawley rat (SD rat) were obtained from CLEA
Japan Inc. (Tokyo, Japan). Two rats were used for isolation of bone marrow cells, and ten rats
were used for in vivo implantation study. These all protocols were approved by the Animal
Experimentation Committee of Osaka University.
Experimental setup of low-pressure, low-frequency plasma treatment
The plasma treatment was carried out under the same processing conditions as those used in
the previous report [21]. Schematic diagrams of the plasma system used presently are shown
in Fig 1, where a side view of the discharge chamber along its quartz glass tube, a cross-sec-
tional view of the discharge chamber, and a photograph of a typical discharge are given in (A),
(B), and (C), respectively. The discharge system consists of a 12 cm long cylindrical quartz
glass tube with inner and outer diameters of 1.7 cm and 2.1 cm, respectively; a powered elec-
trode made of a Cu film placed around the tube, and a metal (SUS) rod inserted at the center
of the quartz tube that functions as the grounded electrode. The Cu electrode attached to the
outside of the quartz tube was powered by a 40 kHz sinusoidal voltage with an amplitude of
2.1 kV. Individual gases are independently controlled and adjusted to maintain a desired gas
pressure whilst the system is pumped by a rotary pump. A photograph (C) illustrates an overall
uniform and stable glow discharge formed in a He/O2 admixture gas (with the pressure ratio
of 5 : 1) at a total pressure of 0.6 kPa.
Surface wettability of plasma-treated HA
Hydrophilicity of the surface, often considered a measure of biocompatibility of blood-
contacting implants, was evaluated using non-porous HA pellets (CELLYARD™, Pentax).
The change in hydrophilicity of the HA surface after plasma treatment was characterized
by the measurement of contact angles using a drop shape analysis device (PG-X, Matsubo,
Japan). Under ambient conditions (50% relative humidity, 21˚C), measurements of the
contact angles of HA pellets were performed with deionized water as a test liquid immedi-
ately after plasma treatment of their surfaces. The surface free energies were subsequently
calculated based on the Owens–Wendt–Raabe method.
Water penetration of porous HA biomaterials treated by low-pressure
plasma
To evaluate water penetration of IP-CHA discs, which depends on the hydrophilicity of inter-
nal pores, we observed penetration of deionized (DI) water containing a contrast medium
(CM, eventually 6% Oypalomin in DI water) into IP-CHA discs using microfocus computer-
ized tomography (μCT). Before the observation by μCT, each IP-CHA disc was entirely
immersed in this contrast-enhanced water for 10 minutes and then placed in a μCT system
(SMX-100CT-SV; Shimazu, Kyoto, Japan). The x-rays were shielded by a brass film placed in
front of the radiation source, eliminating interface scattering and beam hardening effects.
Three-dimensional (3D) image data showing the locations of the CM solution in an IP-CHA
disc were reconstructed from 2D μCT data with the use of the TRI3DBON software package
(Ratoc System Engineering, Tokyo, Japan). For quantitative analysis, we defined the penetra-
tion fraction p of the CM solution as p = 100 × VCM / VP, where VCM and VP represent the vol-
ume of the CM solution and the volume of pores inside the IP-CHA disc [20].
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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In vitro cell proliferation
Cell proliferation on HA coated surfaces was measured using the WST-8 [2-(2-methoxy-
4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2Htetrazolium, monosodium salt]
assay with Cell Counting Kit-8 (Dojindo, Kumamoto, Japan). MC3T3-E1 cells were cultured
in a non-osteogenic standard medium on untreated and plasma-treated HA-coated culture
plates (BD BioCoat™ Osteologic™) at an initial density of 3 × 103 cells per well. The non-osteo-
genic standard medium consisted of α Eagles’s minimal essential medium (αMEM, Gibco,
ThermoFisher Scientific, Waltham, MA, USA) containing 10% fetal bovine serum (Lot
No.002095, JRH Bioscience, Lenexa, KS, USA), and antibiotics (100 U/ml of penicillin, 100 μg/
ml streptomycin, and 0.25 μg/ml of amphotericin B; Sigma-Aldrich, St. Louis, MO, USA).
At 1, 2, and 4 day time points, 10 μL of the Cell Counting Kit solution was added into each
well, followed by incubation of the culture plates at 37˚C in 5% CO2 for 2 hours. The absor-
bance was read at 450 nm with an automatic enzyme-linked immunosorbent assay reader
(Multiskan Ascent MS353; Thermo Fisher Scientific).
Fig 1. Outline of the experimental settings. Schematic illustration of the discharge system used in this study. A side view (A) of the discharge chamber and its
cross section (B). (C) A photograph of a typical discharge with a He/O2 gas admixture with a pressure ratio of 5:1, total pressure of 0.6 kPa, an operating voltage
(zero-to-peak) of 2.1 kV, and a frequency of 40 kHz. An IP-CHA disc of 5 mm diameter (φ) and 2 mm height (h) is seen in the discharge chamber.
https://doi.org/10.1371/journal.pone.0194303.g001
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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Combination of rat mesenchymal cells (MMCs) and IP-CHA disc
Rat marrow mesenchymal cells (MMCs) were obtained from the bone shaft of the femora of
7-week-old Sprague-Dawley male rats. After sacrifice with CO2 inhalation, both ends of the
femur were removed from the epiphysis; the marrow was flushed out using 10 mL of the afore-
mentioned standard medium expelled from a syringe through a 21-gauge needle according to
the method developed by Maniatopoulos et al [22]. The released cells were collected in two T-
75 flasks (Corning, NY, USA) containing 15 mL of the standard medium. The medium was
changed after 24 h to remove hematopoietic cells, and renewed three times a week. Cultures
were maintained in a humidified atmosphere of 95% air with 5% CO2 at 37˚C. After 7 days in
primary culture, adherent MMCs were released from the culture substratum using 0.1% tryp-
sin. The cells were concentrated by centrifugation at 900 rpm for 5 min at 4˚C and resus-
pended at 106 cells/mL. The untreated and plasma-treated IP-CHA discs were soaked in 4 mL
of cell suspension (106 cells/ml) overnight in a CO2 incubator. After the overnight incubation,
these MMCs/IP-CHA composites were transferred into a 24-well plate (Corning) for subcul-
tures. DNA content of the MMCs/IP-CHA composite was measured as a cell proliferation
assay with IP-CHA discs. Each MMCs/IP-CHA composite was subcultured for 7 days in the
non-osteogenic standard medium. After crushing and sonicating each composite, total cellular
DNA was extracted using DNeasy Tissue Kit (QIQGEN, Valencia, CA, USA) according to the
product manual, and the DNA concentration of the lysate was determined by measurement of
the absorbance at 260 nm (A260) in a spectrophotometer (Nanodrop 2000, Thermofisher
scientific).
In vitro osteogenic differentiation
To evaluate how the untreated and plasma-treated IP-CHA discs support in vitro osteogenic dif-
ferentiation of MMCs, we subcultured each MMCs/IP-CHA composite in osteogenic medium
supplemented with 10 mM of β-glycerophosphate, disodium salt, pentahydrate (Calbiochem,
Darmstadt, Germany), 82 μg/ml of L-ascorbic acid phosphate magnesium salt n-hydrate (Wako
Pure Chemical Industrials, Osaka, Japan), and 10−8 M of dexamethasone (Dex, Sigma-Aldrich).
The medium was renewed three times a week, and the subculture was maintained for 2 weeks.
At the end of each subculture period, these MMCs/IP-CHA composites were washed twice with
phosphate-buffered saline (PBS), prepared for the staining with alkaline phosphatase (ALP),
and evaluated for ALP activity. In the evaluation of the efficacy of in vitro osteogenesis, the sub-
cultures in the non-osteogenic standard medium were referred to as ‘no osteogenic induction’.
ALP activity was measured as reported previously [23, 24]. In brief, each MMCs/IP-CHA com-
posite was crushed, homogenized in 0.2% Nonidet P-40 containing 1 mM MgCl2, and centri-
fuged at 10,000 rpm for 1 min at 4˚C. The supernatant was assayed for ALP activity using
p-nitrophenyl phosphate as a substrate. ALP was represented as μmol of p-nitrophenol released
per composite for 30 min of incubation at 37˚C. The total protein content of those samples,
which reflects the cell number, was measured by Bio-Rad Protein Assay (Bio-Rad, Hercules,
CA, USA) to standardize the ALP activity values.
Implantation of IP-CHA in rat calvarial defects
Ten 7-week-old (300–400 g) Sprague-Dawley male rats used in this study were handled in
accordance with a protocol approved by the institutional ethical committee. All surgeries were
performed under sterile conditions in an animal laboratory surgical suite. Under anesthesia
with intraperitoneal injection of a mixture of 0.5 mg/kg medetomidine, 4.0 mg/kg midazolam,
and 5.0 mg/kg butorphanol, two full-thickness bone defects with a diameter of 5 mm were cre-
ated symmetrically in the dorsal part of the parietal bone lateral to the sagittal suture using a
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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trephine bur without dura perforation [25]. The plasma-treated and untreated IP-CHA discs
were implanted in the right and left holes, respectively [21]. Five rats were sacrificed at 4
weeks, and another five at 8 weeks with CO2 inhalation. Histology and μCT analysis were per-
formed to evaluate new bone formation in the inner pores.
X-ray photoelectron spectroscopy (XPS) analysis
X-ray photoelectron spectroscopy (XPS) analysis was performed using ESCA-850 (Shimadzu,
Kyoto, Japan) in order to determine the chemical composition of IP-CHA after plasma treat-
ment [26, 27]. The X-ray source of the XPS system was a magnesium anode biased at 8 kV
with a current of 30 mA, which emits non-chromatic Mg Kα line with a photon energy of
1,253.6 eV and an energy spread of 0.7 eV. The pass energy for photoelectrons was set at 75 eV
with an photoelectron energy analyzer resolution of 0.1 eV. The pressure in the XPS analysis
chamber was set below 2.0 × 10−6 Pa. Prior to each XPS measurement, surface contamination
(mostly by carbon) was removed by Ar-beam etching for 2 seconds in the XPS system. Since
the diameter of collimated X-ray irradiation region is about 8 mm, the nearly entire area of the
IP-CHA surface facing the X-ray source is exposed to the X-ray. Therefore the XPS system
provides data averaged over the sample surface. The relative surface concentration of each
chemical element was determined from the corresponding high-resolution narrow-scan spec-
trum, using symmetrical Gaussian peak shapes and integrated background subtraction. The
peak positions were determined in the curve fitting process according to tabulated chemical
shifts [28]. XPS measurements were performed for multiple IP-CHA samples of the same
nature in each category to ensure statistical significance of the obtained data.
Microfocus computed tomography (μCT)
To evaluate the penetration of CM in vitro and the formation of new bone in vivo in each
IP-CHA disc, we used μCT system (SMX-100CT-SV; Shimadzu). Each sample was scanned at
10 μm intervals at 50 kV and 200 μA. Analysis was performed in superprecision mode at seven
times magnification, with an image intensifier of 1.8 inch in diameter. After scanning, 3D-CT
images were reconstructed, and a discoid image (φ5 mm, 2 mm height) was extracted from the
center of each IP-CHA disc. An additional discoid image (φ2.5 mm, 0.67 mm height) of each
in vivo sample was extracted from the innermost twelfth region (with a half diameter and a
one-third height of the implant ) and the bone formation close to the core of the implant was
evaluated. The volume of CM- or bone-filled pores was measured using the TRI3DBON Soft-
ware package (Ratoc System Engineering, Tokyo, Japan).
Histological evaluation
Decalcified sections were obtained in the following manner; 5 implants harvested from each
group at 4 and 8 weeks were fixed in 10% buffered formalin, decalcified in K-CX solution
(Falma Co., Tokyo, Japan), dehydrated through ethanol series, and embedded in paraffin.
4 μm thick sections were cut parallel to the anatomical coronal planes through the axes of
IP-CHA discs, then stained with hematoxylin and eosin (HE) for light microscopy.
Statistical analysis
Statistical analysis was performed with unpaired t-test with software, STATVIEW version 4.5
(SAS Institure Inc., Cary, NC). The statistical significance level was set at p = 0.05.
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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Results
Surface wettability of non-porous HA treated by low-pressure plama
Water drops placed on non-porous HA surfaces treated with plasma for a duration of 30 minutes
spread immediately and their contact angles were too small to be measured. The plasma exposure
was therefore reduced to 5 minutes and optimized for contact angle assessment. Photographs of
water drops are displayed in Fig 2A and 2B; quantitative analysis in Fig 2C indicates significant
difference in the contact angle and surface free energy between the untreated and plasma-treated
group (72.6 ± 3.89˚ vs 13.8 ± 1.43˚, p< 0.05) (38.8 ± 1.42 mN/m vs 60.1 ± 0.51 mN/m, p< 0.05).
The decrease of contact angle and increase of surface energy verifies that a low-pressure plasma
treatment leads to a significant increase in hydrophilicity of the non-porous HA.
Water absorbability of inner porous HA biomaterials using μCT analysis
The untreated discs remained afloat in water after 10-minute soaking (Fig 3A). By contrast,
plasma-treated discs submerged in water immediately, indicating increased water absorbability,
which is dependent on hydrophilicity of inner pore surfaces. Both discs were subsequently eval-
uated by μCT regarding the penetration of a CM solution into the inner pores. The μCT 3D
images of untreated (Fig 3B) and plasma-treated IP-CHA discs (Fig 3C) are shown in Fig 3.
Each image constitutes three parts; yellow for HA, blue for empty space (i.e. unfilled pores) and
pink for the CM solution (i.e. CM filled pores). With plasma treatment, most pores became
filled with the CM solution, supporting the increase in hydrophilicity of inner pore surfaces.
Quantitative analysis further demonstrated that the penetration fraction of inner pores was sig-
nificantly increased by the plasma treatment (Fig 3D, 10.9 ± 2.97% vs 76.9 ± 3.19%, p< 0.05).
Fig 2. Change of surface wettability after 5 min of plasma treatment. Photographs of water drops on the surfaces of
non-porous HA pellets. (A) untreated and (B) plasma-treated pellets. (C) Quantitative analysis of contact angles and
surface energy. Data were expressed as mean ± standard deviation (SD).
https://doi.org/10.1371/journal.pone.0194303.g002
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In vitro cell proliferation analysis
The WST-8 assay using MC3T3-E1 cells and HA-coating plates demonstrated no significant
difference in cell proliferation between the untreated and plasma-treated groups at each time
point (Fig 4A). IP-CHA discs combined with rat marrow mesenchymal cells (MMCs) were
cultured in non-osteogenic growth medium for 7 days, and DNA content of these MMCs/
IP-CHA composites were measured. Likewise, no significant difference was found in the DNA
content per composite between two groups (Fig 4B). Data in Fig 4 were represented as mean
values ± standard deviation of 2 independent triplicate experiments.
In vitro osteogenic differentiation of MMCs / IP-CHA composites
After the osteogenic subculture for 14 days, the MMCs/IP-CHA composites were evaluated.
ALP staining was more intensively detected in the osteogenic-differentiated group (as seen in
‘untreated’ and ‘plasma-treated’ of Fig 5A), with further enhancement in the plasma-treated
Fig 3. Analysis of water penetration into IP-CHA. (A) Photographs of untreated and plasma-treated IP-CHA discs (φ5 mm × h2 mm) soaked in the deionized
water containing 6% contrast medium (CM, Oypalomin™). Both discs were soaked in the CM solution for 10 minutes, and evaluated by μCT regarding
penetration of CM solution into inner pores. The μCT cross section at half height (left) and 3D (right) images of untreated (B) and plasma-treated IP-CHA discs
(C). Each image is composed of three parts: yellow for HA, blue for empty space (i.e. unfilled pores) and pink for the CM solution (i.e. CM filled pores). (D)
Penetration fraction of inner pores was calculated. Data were expressed as mean ± SD.
https://doi.org/10.1371/journal.pone.0194303.g003
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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group. Quantitative analysis demonstrated that ALP activity was highest in the plasma-treated
group (Fig 5B: 0.165 ± 0.010 in ‘untreated’, and 0.253 ± 0.018 in ‘plasma-treated’). Conversely,
the total protein content of the composites was significantly lower under osteogenic differenti-
ation without any difference between ‘untreated’ and ‘plasma-treated’ groups (Fig 5C:
0.165 ± 0.010 in ‘untreated’, and 0.253 ± 0.018 in ‘plasma-treated’). This suggests that, unlike
the ‘no osteogenic induction’ group subcultured in the standard medium, the MMCs in the
other two groups despite not proliferating intensely, differentiated into osteogenic lineages.
Accordingly, the standardized ALP activity divided by the corresponding total protein content
significantly increased in the plasma-treated group as compared with the untreated group and
the group of ‘no osteogenic induction’. (Fig 5D: 0.617 ± 0.038 in ‘no osteogenic induction’,
2.089 ± 0.228 in ‘untreated’, and 3.263 ± 0.288 in ‘plasma-treated’).
X-ray photoelectron spectroscopy (XPS) analysis
To examine the change in surface chemical composition of IP-CHA by plasma treatment, we
have performed XPS measurements of untreated and plasma-treated IP-CHA sample surfaces.
The results are summarized in Table 1, where the corresponding theoretical values of stoichio-
metric HA, i.e., Ca10(PO4)6(OH)2, are also listed as a reference. Quadruplicated (n = 4) XPS
measurements were performed for untreated IP-CHA samples and triplicated (n = 3) mea-
surements were performed for plasma treated IP-CHA. It is evident that the surface of an
untreated IP-CHA used in this study was not stoichiometric HA. The IP-CHA surface had a
higher Ca to P atomic concentration ratio (Ca/P) and a lower O to Ca atomic concentration
ratio (O/Ca) than the stoichiometric HA, which suggests that IP-CHA consisted of a mixture
of stoichiometric HA and other calcium phosphates [26, 27]. It is seen that, by plasma treat-
ment, the mean values of O/P and O/Ca increased from 4.27 and 3.39 to 6.07 and 4.78, respec-
tively, with the corresponding P values of 8.7× 10−4 and 8.3 × 10−3 (i.e., P < 0.01), indicating
that the increase of O atoms on the IP-CHA surface by plasma treatment was statistically
significant.
Knowing that the oxygen content on the IP-CHA surface increased significantly by plasma
treatment, we now check if there was any other significant change in surface chemical composition
Fig 4. Cell proliferation on HA surfaces in non-osteogenic culture. (A) WST-8 assay for MC3T3 cultured on HA-coated plates at day 1, 2
and 4. Blue and red lines denote untreated and plasma-treated groups, respectively. (B) DNA content of IP-CHA discs (φ5 mm × h2 mm)
combined with rat MMCs. The MMCs/IP-CHA composites were cultured in non-osteogenic growth medium for 7 days. Data were
represented as mean ± SD of 2 independent triplicate experiments.
https://doi.org/10.1371/journal.pone.0194303.g004
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Fig 5. In vitro osteogenesis of IP-CHA discs combined with rat MMCs. (A) Alkaline phosphatase (ALP) staining of IP-CHA discs, which were
combined with MMCs and cultured in vitro for 14 days in non-osteogenic or osteogenic differentiation medium. Each graph is composed of three groups:
no osteogenic induction (left), plasma-untreated (center), and plasma-treated (right) IP-CHA discs. ALP activity (B) and content of total protein (C) per
MMCs/IP-CHA composite. (D) ALP activity normalized by the content of total protein. Data were represented as mean ± SD of 2 independent triplicate
experiments.
https://doi.org/10.1371/journal.pone.0194303.g005
Table 1. The surface atomic concentration ratios obtained from XPS.
Atomic concentration ratios
Ca/P O/P O/Ca
Stoichiometric HA theoretical values 1.67 4.33 2.60
Untreated IP-CHA 1.21±0.15 4.27±0.26 3.39±0.48
Plasma-treated IP-CHA 1.27±0.05 6.07±0.31 4.78±0.05
Atomic concentration ratios of calcium to phosphor (Ca/P), oxygen to phosphor (O/P), and oxygen to calcium (O/
Ca) on the surfaces of untreated IP-CHA and plasma treated IP-CHA obtained from XPA measurements.
Measurements are quadruplicated (n = 4) for untreated IP-CHA and triplicated (n = 3) for plasma-treated IP-CHA.
Data are expressed as mean ± SD. As a reference, the corresponding theoretical values of stoichiometric HA, i.e.,
Ca10(PO4)6(OH)2, are also listed in the first row. It is seen that, in the plasma-treated IP-CHA (n = 3), the relative
surface concentration of O increased significantly, whereas the Ca/P ratio remains unaltered.
P < 0.01; compared to untreated IP-CHA (n = 4).
https://doi.org/10.1371/journal.pone.0194303.t001
Non-thermal plasma surface modification and porous hydroxyapatite ceramics
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by plasma treatment. Fig 6A shows representative samples of XPS wide scans for a plasma-treated
surface of an IP-CHA disc that faced the quartz glass surface during the plasma treatment (the top
curve in blue), a plasma-treated surface of an IP-CHA disc that faced the stainless-steel metal elec-
trode during the plasma treatment (the middle curve in red), and an untreated surface of an
IP-CHA disc (the bottom curve in black). As indicated by the broken oval in Fig 6A, the O1s peak
of the IP-CHA surface increased notably after plasma treatment, in agreement with our discussion
above. It is also seen that the Fe peaks appeared on the IP-CHA surface that faced the metal elec-
trode, whereas the Si peaks appeared on the surface that faced the quartz glass. It is most likely that
Fe atoms on the IP-CHA surface were originated from the stainless steel electrode sputtered by
the plasma, whereas Si atoms on the IP-CHA surface were originated from the quartz wall also
sputtered by the plasma. Although signals of Fe and Si are seen in XPS, these peaks are known to
Fig 6. Wide scan XPS analysis of IP-CHA discs. (A) Wide scan spectra. It is seen that the O1s peak of the IP-CHA surface increased notably after
plasma treatment (broken oval). The Fe peaks appear on the IP-CHA surface that faced the metal electrode (red), whereas the Si peaks appear after
plasma treatment, more significantly so on the surface that faced the quartz glass (blue). (B) ,(C), and (D) are narrow scan spectra of O1s for the IP-CHA
surface without plasma treatment, the top surface of an IP-CHA disc with plasma treatment, and the bottom surface of an IP-CHA disc with plasma
treatment, respectively. We consider that C is a contaminant and Si comes from the quartz glass wall of the discharge chamber.
https://doi.org/10.1371/journal.pone.0194303.g006
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be relatively sensitive (i.e., large even when a small amount of the corresponding species exists)
and we have confirmed that the atomic percentages of Fe and Si were negligibly small. Similarly a
small amount of carbon is observed in both untreated and plasma-treated IP-CHA and hardly
affects the atomic concentration ratios among Ca, P, and O, i.e., constituting atoms of HA, which
suggests the observed carbon is an inconsequential part (most likely contamination by ambient
air) of the IP-CHA surface. We also note that no nitrogen peak is seen in either untreated or a
plasma-treated surface. Thus we have concluded that the only confirmed significant change in sur-
face chemical composition of IP-CHA by plasma treatment is the increase of O atoms.
Fig 6B–6D also shows sample narrow scan spectra of O1s for the IP-CHA surface in untreated
IP-CHA (Fig 6B), the top surface of a plasma-treated IP-CHA disc (Fig 6C), and the bottom sur-
face of a plasma-treated IP-CHA disc (Fig 6D), corresponding to the three cases shown in (Fig
6A). The spectra were fitted with 4 possible chemical shifts, i.e., C-O, Si-O, Ca-O, and phosphate
or hydroxyl ions (i.e., PO4
3- or OH-). The Ca-O chemical shift seems to have increased after pl-
asma treatment, but it is not conclusive from these findings here. A further study is needed to
determine how the increased oxygen is bonded in the plasma treated IP-CHA.
μCT analysis of newly formed bone volume
To measure the total bone volume in the plasma-treated/untreated IP-CHA discs after in vivo
implantation, we performed μCT analysis as previously reported [24]. In Fig 7, the μCT images
Fig 7. In vivo implantation of IP-CHA discs. (A) Images of μCT analysis of untreated and plasma-treated IP-CHA discs at 4 and 8-week time points after
implantation. Yellow denotes the bony density (i.e. IP-CHA and newly-formed bone inside the pores). (B) Pink denotes the bony density in the discoid
images (φ2.5 mm, 0.67 mm height) extracted from the innermost twelfth part of the implant. Quantitative analysis of newly formed bone in the whole (C)
and the innermost part (D) of the IP-CHA disc. Data were represented as mean ± SD of 5 animals.
https://doi.org/10.1371/journal.pone.0194303.g007
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Fig 8. Histological images of IP-CHA discs after in vivo implantation. Hematoxylin & Eosin-staining of IP-CHA discs
at 4 and 8 weeks after in vivo implantation (A and B respectively). Scale bars = 200 μm. At both time points, the bone
formation in the pores of the implants was observed in the bottom region close to the brain surface, which is known to be
rich in blood supply; less bone was produced with increasing distance from the bottom region to the top surface of the
implant. Overall, the plasma-treated discs had more bone formation in the pores compared to untreated controls (top in
A&B). In the close-up images (bottom in A&B), the plasma-treated discs demonstrated bone ingrowth even in the core
region at 4 weeks, while the untreated controls did not. At 8 weeks, the progress of bone ingrowth reached the core
regions of both untreated and plasma-treated implants, with the plasma-treated implants having slightly more bony
tissue.
https://doi.org/10.1371/journal.pone.0194303.g008
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display areas having bony high (yellow) and low (black) intensities (Fig 7A). The yellow region,
representing the wall of IP-CHA and bone matrices newly formed in the inner pores, was
larger in the plasma-treated group than in untreated at 4 weeks, with a slight difference at 8
weeks. This potential superiority of plasma-treated group in osteoconductivity is mo.
Quantitative analysis demonstrated that plasma-treated IP-CHA had significantly higher
bone volume than untreated IP-CHA at 4 weeks (Fig 7C: 3.98 ± 0.75 mm3 vs 4.93 ± 0.57 mm3,
P< 0.05). However, the bone volume at 8 weeks did not reach statistical significance (Fig 7C:
7.01 ± 0.97 mm3 vs 7.88 ± 0.93 mm3, P > 0.05). Additionally, between the two groups, the vol-
ume of new bone in the innermost twelfth region had more distinctive difference, which
reached the statistical significance at 4 weeks but not at 8 weeks (Fig 7D). These data were con-
sistent with the results of histological analyses shown in Fig 8.
Histological analysis after in vivo implantation
At 4 and 8 weeks (Fig 8A and 8B, respectively), the bone formation in the pores of the implants
was observed in the bottom region close to the brain surface, which is known to be rich in
blood supply; less bone was produced with increasing distance from the bottom region to the
top surface of the implant. At both time points, the plasma-treated discs had more bone forma-
tion in the pores compared to the untreated controls (top in Fig 8A and 8B). To closely observe
the ingrowth of bony tissue, we magnified the center of each disc (approximately one-third of
the disc diameter) and drew blue dashed lines at one-third and two-thirds of the disc’s height
(bottom in Fig 8A and 8B). Therefore, the region between the blue dashed lines is the core of
the interconnected porous implant and farthest from its outer surface. In the plasma-treated
group, the bone formation inside the pores of IP-CHA was visible even in the core region at
4 weeks. However, essentially no bone formation was observed in the core region of the un-
treated group at 4 weeks. Further, the bone ingrowth progression was steadily upward and
reached the core region at 8 weeks in both untreated and plasma-treated implants, with the
plasma-treated implants having slightly more bony tissue.
Discussion
Among various surface modification approaches available for biomaterials, plasma treatment
has many attractive features; it is solvent-free, has low chemical consumption, and requires no
sterilization [29]. A variety of plasmas with varying excitation methods from different gas
sources have been used to improve physical and biological properties of target material sur-
faces [18, 30, 31]. In fact, plasma treatments for HA surfaces have been well reported in litera-
tures, but these studies are limited to atmospheric plasma or low pressure ion implantation
using radio frequency plasma [19, 32]. The present study is the first to demonstrate the feasibil-
ity of low-pressure and low-frequency plasma to process a HA-based porous material and
facilitate its osteoconductivity.
Osteoconduction of an implant surface, i.e., the process that guides the growth of a bony tis-
sue directly bound to the surface, is closely associated with the susceptibility of bone ingrowth.
It is one of the most important factors in the development of new artificial bone substitutes.
Few studies have employed similar strategies to enhance the osteoconductivity of porous HA
using different processing techniques, which efficiently facilitate new bone formation on HA
surfaces [10, 33]. Recent studies have now revealed that surface modification of HA with pl-
asma, an easy and economical technique, can further improve its surface hydrophilicity and
mineralization [19] and penetrate its porous structures via interpore connections [34, 35].
In a previous study, some of the present authors showed that both gas pressure and treat-
ment time affect the efficacy of plasma treatment by facilitating water penetration into a
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plasma-treated porous material (IP-CHA), and determined the optimal process parameters for
low-pressure, low-frequency plasma processes of IP-CHA [21]. Using those parameters in the
present study, we discovered that the penetration of contrast-enhanced water into plasma-
treated IP-CHA discs (5 mm diameter, 2 mm height) was promoted owing to increased hydro-
philicity on the outer surfaces of IP-CHA discs and inner walls of their pores. Immersion of
IP-CHA discs in solution, however, can be influenced by trapped air within the pores, which
can impede or even prevent further penetration of the solution into the pores unless ventilated
or absorbed by the solution. Therefore, the penetration fraction p shown in the present study
may not completely reflect hydrophilicity of the inner pore surfaces. However, it remains a
sound indicator of water absorbability of the porous materials [21].
Plasma treatment can enhance the in vivo osteoconductivity of HA-based materials.
Although pro-osteogenic modification of HA surfaces was achieved by plasma treatment in
vitro, no previous study demonstrated its efficacy in vivo [19]. In the present study, bone
ingrowth into a porous HA was accessed in a rat calvarial defect model. Histological analysis
in coronal sections demonstrated better bone ingrowth into IP-CHA discs at the regions
close to the epidural space, thus probably rich in blood supply. Quantitative μCT analysis
revealed that the new bone volume in the IP-CHA discs significantly increased by plasma
treatment at 4 weeks, with no difference between groups at 8 weeks. These results suggest
that plasma treatment of IP-CHA facilitates bone ingrowth especially at an early stage of
bone healing. Clinically, the effect induced by plasma treatment can rapidly increase the
mechanical strength of IP-CHA implants, resulting in early weight bearing and faster
rehabilitation.
Interestingly, in the core region which comprises the innermost area with a twelfth volume
of the whole, the new bone formation was significantly greater at 4 weeks in the plasma group.
This trend of superiority was also observed at 8 weeks, despite not reaching statistical signifi-
cance. The enhancement in osteoconduction by plasma treatment was most noticeable in the
core region than in the whole IP-CHA disc. This is due to the interconnected pores of the core
which enables sufficient plasma-induced osteoconductivity. Further, considering that the im-
provement in the innermost region requires the penetration of fluid and cells, the increased
water absorbability of IP-CHA discs by plasma treatment may have strongly affected the in
vivo experiment. Therefore, the enhanced in vivo osteoconduction observed in this study may
be due, in part, to the increased water absorbability, along with some pro-osteogenic changes
of the material surface [19].
Changes in the surface chemical composition, which may be responsible for the biological
response of cells contacting the material, were elucidated by XPS analysis. The observed
increase in concentration of oxygen (O) at the surface of IP-CHA is similar to reports in other
studies examining plasma treatment of polymer surfaces [19, 36, 37]. Although it is unclear
from the XPS data how O atoms were incorporated in the surface atomic structures, we sur-
mise that most O atoms were incorporated as negatively charged hydroxyl (OH) groups near
positively charged Ca atoms on the surface, based on the fact that IP-CHA becomes highly
hydrophilic after plasma treatment and hydroxyapatite is known to adsorb further hydroxyl
ions (OH-) in a weakly alkaline electrolyte solution [38]. However a further study is needed to
determine surface chemical structures of IP-CHA after plasma treatment. Unlike the previous
study using atmospheric plasma [19], no substantial change in the concentration of nitrogen
(N) was observed before and after the plasma treatment in this study. This is reasonable as we
had no intentional admixture of air in the He/O2 plasma. Hence, the difference in findings
between our study and the previously published study that implicated nitrogen in the en-
hanced proliferation of the cells cultured on HA coatings suggests that the efficacy of plasma
treatment is highly dependent on the gases used for plasma generation.
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Our findings suggested that plasma treatment can enhance the in vivo osteoconductivity of
IP-CHA through increased water absorbability and pro-osteogenic surface modification. The
application of plasma to commonly used artificial bones is a simple and easy modification of
preexisting biomaterials that can substantially enhance their bone healing and regenerative
properties.
Conclusions
The present study demonstrated that plasma application to IP-CHA, a widely used bone sub-
stitute, enhanced its in vitro and in vivo performance as a bone substitute. Further optimization
of plasma treatment and longer term follow-up of its in vivo application will facilitate its use in
a clinical setting.
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